Bibliography

Abraira C; Henderson WG; Colwell JA; Nuttall FQ; Comstock JP; Emanuele NV; Levin SR; Sawin CT; Silbert CK . Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. Diab Care 1998; 21:574-79

Abraira C; Colwell JA; Nuttall FQ; Sawin CT. Veterans Affairs cooperative study on glycemic control and complications in type II diabetes (VA CSDM). Diab Care 1995; 18:1113-23

Agardh E; Agardh CD; Koul S; Torffvit O. A Four-Year Follow-up Study on the Incidence of Diabetic Retinopathy in Older Onset Diabetes Mellitus. Diabet Med 1994; 11:273-78

Agurs-Collins TD; Kumanyika SK; Ten-Have TR; Adams-Campbell LL. A randomized controlled trial of weight reduction and exercise for diabetes management in older African-American subjects. Diab Care 1997; 20(10):1503-11

Ahroni J. Teaching foot care creatively and successfully. Diabetes Educator 1993; 19(4):230-34

Alogna M. CDC Diabetes Control Programs-Overview of Diabetes Patient Education. Diabetes Educator Winter 1985; 10:32-36

American College of Sports Medicine. ACSM’s Guidelines for Exercise Testing and Prescription. Fifth Edition. Baltimore, MD: Williams & Wilkins, c1995

American Diabetes Association: Clinical Practice Recommendations 1999. Management of dyslipidemia in adults with diabetes. Diab Care 1999; 22:Supplement 1, S56

American Diabetes Association. Standards of Medical Care for Patients with Diabetes Mellitus. Diab Care 1999:22 S1:35

American Diabetes Association. Meeting the Standards. Standard 12. National Standards for Diabetes Self-Management Education Program Recognition Application Manual. Alexandria, VA: American Diabetes Association, c1998

American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diab Care 1998; 21(S1):S8, 23-31

American Diabetes Association. Screening for Type 2 Diabetes. Position Statement. Diab Care 1988; 21(Suppl. 1);S20-22

American Diabetes Association. Position Statement: Diabetic Nephropathy. Diab Care 1997;20(S1):S24-S27

American Diabetes Association. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diab Care 1997; 20:1183-97

American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diab Care 1995; 18:8-15

American Diabetes Association and The American Dietetic Association. The First Step in Diabetes Meal Planning. Alexandria, VA: American Diabetes Association, c1995

American Diabetes Association. Census development conference on the diagnosis and management of nephropathy in patients with diabetes mellitus. Diab Care 1994; 17:1357-61

American Diabetes Association Position Statement. Implications of the diabetes control and complications trial. June 1993

Anderson JH; Brunell RL; Keohane P; Koivisto VA; Trautmann ME; Vignati L; DiMarchi R. Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Arch Intern Med 1997; 157:1249-55

Anderson RM; Funnell MM; Butler PM; Arnold MS; Fitzgerald JT; Feste CC. Patient empowerment. Results of a randomized controlled trial. Diab Care 1995; 18(7):943-49

Arseneau DL; Mason AC; Wood OB; Schwab E; Green D. A comparison of learning activitiy packages and classroom instruction for diet management of patients with non-insulin-dependent diabetes mellitus. Diabetes Educator 1994; 20(6):509-14

Aubert RE; Herman WH; Waters J; Moore W; Sutton D; Peterson BL. Nurse Case Management to improve glycemic control in a diabetic patients in a health maintenance organization. A randomized controlled trial. Ann Intern Med 1998; 129:605-712

Avins AL; Browner WS. Lowering risk without lowering cholesterol: implications for national cholesterol policy. Ann Intern Med 1996; 125:502

Babcock DE; Miller MA. Client education: theory & practice. St. Louis, MO: Mosby, c1994

Bailey TS; Yu HM; Rayfield EJ. Patterns of foot examination in a diabetic clinic. AJM 1985; 78:371-374

Barth R; Campbell LV; Allen S; Jupp JJ; Chisholm DJ. Diabetic Medicine 1991; 8:111-117

Bayraktar M; Van Thiel DH; Adalar N. A comparison of acarbose versus metformin as an adjuvant therapy in sulfonylurea-treated NIDDM patients. Diab Care 1996; 19:252-54

Becerra JE; Khoury MJ; Cordero JF; Erickson JD. Diabetes mellitus during pregnancy and the risks for specific birth defects: a population-based case-control study. Pediatrics 1990 Jan; 85(1):1-9

Becton Dickinson Consumer Products. Getting Started (R). Controlling Low Blood Sugar Reactions. Franklin Lakes, NJ: Becton Dickinson and Company, n/d

Behounek BD; McGovern ME; Kassler-Taub KB; Markowitz JS; Bergman M. A multinational study of the effects of low-dose pravastatin in patients with non-insulin-dependent diabetes mellitus and hyper-cholesterolemia. Clin Cardiol 1994; 17:558

Bennett PH; Haffner S; Kasiske BL; Keane WF; Mogensen CE; Parving H-H; Steffes MW; Striker GE. Screening and management of microalbuminuria in patients with diabetes mellitus. Recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney Foundation. Am J Kid Dis 1995; 25:107-12

Beri M; Klugman MR; Kohler JA; Hayreh SS. Anterior Ischemic Optic Neuropathy. VII. Incidence of bilaterality and various influencing factors. Ophthalmology 1987; 94:1020-28

Birke JA; Sims DS. The insensitive foot. In Physical Therapy of the Foot and Ankle. Hunt GC, Ed. New York, NY: Churchill Livingstone 1988; 133-168

Bonomi L; Marchini G; Marraffa M; Bernardi P; De Franco I; Perfetti S; Varotto A; Tenna V. Prevalence of Glaucoma and Intraocular Pressure Distribution in a Defined Population: The Egna-Neumarkt Study. Ophthalmology 1998; 105:209-15

Boyko EJ. A prospective study of risk factors for diabetic foot ulcers. Diabetes 1996; Supplement, p 194

Brink S; Siminerio L; Hinnen-Hentzen D. Diabetes Education Goals. Alexandria, VA: American Diabetes Association, Inc., c1995:63

Brodsky JW; Schneidler C. Diabetic foot infections. Orthop Clin North Am 1991; 22(3):473-89

Brown GC; Margargal LE. Central Retinal Artery Obstruction and Visual Acuity. Ophthalmology 1982; 89:14-19

Buse JB; Gumbiner B; Mathias NP; Nelson DM; Faja BW; Whitcomb RW. Troglitazone use in insulin-treated type 2 diabetic patients. Diab Care 1998; 21:1455-61

Byington RP; Furberg CD; Craven TE; Pahor M; Sowers JR. Isradepine in prediabetic hypertensive subjects. Diab Care 1998; 21:2103-10

Calle-Pascual AL; Garcia-Honduvilla J; Martin-Alvarez PJ; Vara E. Comparison between acarbose, metformin and insulin treatment in type 2 diabetic patients with secondary failure to sulfonylurea treatment. Diabetes Metab 1995; 21:256-60

Campeau L; Knatterud L; Damanski M; Hunninghake DB; White CW; Geller NL; Rosenberg Y. The effect of aggressive lowering of low density lipoprotein cholesterol levels and low-dose anticoagulation of obstructive changes in saphenous-vein coronary-artery bypass grafts. NEJM 1997; 336:153-62

Caputo GM; Cavanagh PR; Ulbrecht JS; Gibbons GW; Karchmer; AU. N Engl J Med 1994 331(31): 854-860

Cavanagh PR; Sanders LJ; Sims DS Jr. The role of pressure distribution measurement in diabetic foot care. Rehabilitation R&D Progress Reports 1987

Chen Ms; Kao CS; Fu CC; Chen CJ. Incidence and progression of diabetic retinopathy among non-insulin dependent diabetic subjects: A 4-year follow-up. Int J Epidermiol 1995; 4:787-95

Chiasson JL; Josse RG; Hunt JA; Palmason C; Rodger NW; Ross SA; Ryan EA; Tan MH; Wolever TM. The efficacy of acarbose in the treatment of patients with non-insulin dependent diabetes mellitus. Ann Intern Med 1994; 121:928-35

Chow C; Tsang L; Sorensen JP; Cockram CS. Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients. Diab Care 1995; 18:307-14

Ciavarella A; Di Mizio G; Stefoni S; Borgnino LC; Vannini P. Reduced albuminuria after dietary protein restriction in insulin- dependent diabetic patients with clinical nephropathy. Diab Care 1987 Jul-Aug; 10(4):407-13

Cockroft DW; Gault HM. Prediction of Creatinine Clearance from Serum Creatinine. Nephron 1976; 16:31-41

Coggins CH; Dwyer JT; Greene T; Petot G; Snetselaar LG; Van Lente F. Serum lipid changes associated with modified protein diets: results from the feasibility phase of the Modification of Diet in Renal Disease study. Am J Kidney Dis 1994 Apr; 23(4):514-23

Conget I; Jansa M; Vidal M; Vidal J; Manzanares JM; Gomis R. Effects of an individual intensive educational control program for insulin-dependent diabetic subjects with poor metabolic control. Diabetes Research & Clinical Practice 1995; 27(3):189-92

Coniff RF; Shapiro JA; Seaton TB. Long-term efficacy and safety of acarbose in the treatment of obese subjects with non-insulin-dependent diabetes mellitus. Arch Intern Med 1994 Nov 14; 154(21):2442-48

Conte MS. Femorotibial bypass for claudication: do results justify an aggressive approach? J Vasc Surg 1995; 21(6):873-881

Coonrod BA; Betschart J; Harris MI. Frequency and Determinants of Diabetes Patient Education Among Adults in the US Population. Diab Care 1994; 852-58

Currie IC. Treatment of intermittent claudication: the impact on quality of life. Eur J Vasc Endovasc Surg 1995; 10:356-361

Cusi K; DeFronzo RA. Metformin: A review of its metabolic effects. Diabetes Reviews 1998; 6:89-131

Cousins L. Pregnancy complications among diabetic women: review 1965-1985. Obstet Gynecol Surv 1987 Mar; 42(3): 140-49

Danese MD; Powe NR; Sawin CT; Ladenson PW. Screening for mild thyroid failure at the periodic health examination. A decision and cost-effective analysis. JAMA 1996; 276:285-92

Dasbach EJ; Fryback DG; Newcomb PA; Klein R. Cost-Effectiveness of Strategies for Detecting Diabetic Retinopathy. Med Care 1991; 29:20-39

Davidson JK; Delcher HK; Englund A. Spin-off Cost Benefits of Expanded Nutritional Care. J Am Dietetic Assoc 1979; 75:250-57

DCCT [Diabetes Control and Complications Trial Research Group]. Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial. Am J Cardiol 1995 May; 75(14):894-903

DCCT Research Group. Expanded role of the dietitian in the diabetes control and complications trial: Implications for clinical practice. J Am Diet Assoc 1993; 93:758-67

DCCT Research Group. The effects of intensive diabetes treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus. NEJM 1993; 329:977-86

DCCT Research Group. Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial. Am J Med 1991; 90(4):450-59

DeFronzo R; Goodman A. Multicenter metformin study group. Efficacy of metformin in patients with non-insulin dependent diabetes mellitus. NEJM 1995; 339:541-49

Demacker PNM; Toenhake-Dijkstra H; de Rijke YB; Stalenhoef AF; Stuyt PM; Williams HL. On the presumed inaccuracy of the Friedewald formula in hypertriglyceridemic plasma: a role for imprecise analysis? Clin Chem 1996; 42:1491-94

Diabetes Control and Complications Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. NEJM 1993; 329:977-86

Diabetes Quality Improvement Project (DQIP), a Federal/Private Sector Coalition

Diabetic Education Pilot Program Experience 1/1/83-6/30/83.BlueCross/Blue Shield of North Dakota Evaluation of the State of Maryland's Diabetes Care Program, Baltimore County Center for Health Program Development and Management. University of Maryland, 1995

Dibble CM; Kochenour NK; Worley RJ; Tyler FH. Effect of Pregnancy on Diabetic Retinopathy. Obstet Gynecol 1982; 59:699-704

Donahue RP; Orchard TJ. Diabetes mellitus and macrovascular complications: an epidemiological perspective. Diab Care 1992; 15:1141-55

Downs JR; et al. for the AFCAPS/TexCAPS Research Group. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. Results of AFCAPS/TexCAPS. JAMA 1998; 279:1615-22

Eastman RC; Javitt JC; Herman WH; Dasbach EJ; Zbrozek AS; Dong F; Manninen D; Garfield SA; Copley-Merriman C; Maier W; Eastman JF; Kotsanos J; Cowie CC; Harris M. Model of complications of NIDDM. I. Model construction and assumptions. Diab Care 1997 May; 20(5):725-34

Eckman MH; Greenfield S; Mackey WC; Wong JB; Kaplan S; Sullivan L; Dukes K; Pauker SG. Foot infections in diabetic patients. Decision and cost-effectiveness analyses. JAMA 1995; 273(9):712-20

Edelman SV; White D; Henry RR. Intensive insulin therapy for patients with type II diabetes. Current Opinion in Endocrinology and Diabetes 1995; 2:333-40

Ederer F; Hiller R; Taylor HR. Senile Lens Change and Diabetes in Two Population Studies. Am J Ophthalmol 1981; 91:381-95

Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial (DCCT). Am J Cardiol 1995 May 1; 75(14):894-903

Ellison GC; Rayman KM. Exemplars' experience of self-managing type 2 diabetes. Diabetes Educator 1998; 24(3):325-30

Estacio RO; Jeffers BW; Hiatt WR; Biggerstaff SL; Gifford N; Schrier RW. The Effect of Nisoldipine as Compared with Enalapril on Cardiovascular Outcomes in Persons with NIDDM and HTN. NEJM 1998; 338:645-52

Evanoff G; Thompson C; Brown J; Weinman E. Prolonged dietary protein restriction in diabetic nephropathy. Arch Intern Med 1989 May; 149(5):1129-33

Faas A; Schellevis FG; van Eijk JTM. The efficacy of self-monitoring of blood glucose in NIDDM subjects. Diab Care 1997; 20:1482-86

Ferris FL. How Effective Are Treatments for Diabetic retinopathy? JAMA 1993; 269:1290-91

Feste C. Empowerment: facilitation a path to responsible self-care. Elkhart, Ind., Miles Inc., Diagnostics Division 1991

Franz MJ; Monk A; Barry B; McClain K; Weaver T; Cooper N; Uphan P; Bergenstal R; Mazze RS. Effectiveness of medical nutrition therapy provided by dietitians in the management of non-insulin dependent diabetes mellitus: a randomized, controlled clinical trial. J Am Diet Assoc 1995; 95:1009-17

Franz MJ; Splett PL; Monk A; Barry B; McClain K; Weaver T; Upham P; Bergenstal R; Mazze RS. Cost-effectiveness of medical nutrition therapy provided by dietitians for persons with non-insulin dependent diabetes mellitus. J Am Diet Assoc 1995; 95:1018-24

Friedewald WT, Levy RI; Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18(6):499-502

Fuhrmann K; Reiher H; Semmler K; Fischer F; Fischer M; Glockner E. Prevention of congenital malformations in infants of insulin-dependent diabetic mothers. Diab Care 1983 May-Jun; 6(3):219-23

Funnell M; Hass L. National standards for diabetes self-management education programs. Diab Care 1995 Jan; 18(1):100-16

Gall M; Rossing P; Skott P; Damsbo P; Vaag A; Bech K; Dejgaard A; Lauritzen M; Lauritzen E. Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type II diabetic patients. Diabetologia 1991; 34:655-61

Gallichan M. Self monitoring of blood glucose by people with diabetes: evidence based practice. BMJ 1997; 314:964-67

Garber AM; Browner WS; & the American College of Physicians. Guidelines for using serum cholesterol, high-density lipoprotein cholesterol, and triglyceride levels as screening tests for preventing coronary heart disease in adults. Ann Intern Med 1996; 124:515

Garcia R; Suarez R. Diabetes education in the elderly: a 5-year follow-up of an interactive approach. Patient Education & Counseling 1996; 29(1):87-97

Glasgow RE; Roobert DJ; Hapmson SE; Brown JE; Lewinsohn PM; Donnelly J. Improving self-care among older patients with type II diabetes: the "Sixty Something…" Study. Patient Education & Counseling 1992; 19(1):61-74

Ginsberg JM; Chang BS; Matarese RA; Garella S. Use of single voided urine samples to estimate quantitative proteinuria. NEJM 1983 Dec 22; 309(25):1543-46

Ginsburg LH; Aiello LM. Diabetic Retinopathy: Classification, Progression, and Management. Focal Points. Clinical Modules for Ophthalmologist 1993; 11:1-14

Giugliano D; Quatraro A; Consoli G; Minei A; Ceriello A; De Rosa N; D'Onofrio F. Metformin for obese, insulin-treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors. Eur J Clin Pharmacol 1993; 44:107-12

Glimepiride for NIDDM. The Medical Letter 38:975, May 24, 1996

Goldberg RB; Einhorn D; Lucas CP; Rendell MS; Damsbo P; Huang WC; Strange P; Brodows RG. A randomized placebo-controlled trial of repaglinide in the treatment of type 2 diabetes. Diab Care 1998; 21:1897-903

Goodkin G. Mortality factors in diabetes. A 20 year mortality study. J Occup Med 1975 Nov; 17(11):716-21

Grundy SM. Statin trials and goals of cholesterol-lowering therapy. Circulation 1998; 97:1436-39

Guidelines Subcommittee. 1999 World Health Organization—International Society of Hypertension Guidelines for the management of Hypertension. J Hyperten 1999; 17:151-83

Haffner SM. Diabetes, hyperlipidemia, and coronary artery disease. Am J Cardiol 1999 May 13; 83(9B): 17F-21F

Haffner SM; Fong D; Stern MP; Pugh JA; Hazuda HP; Petterson JK; VanHeuven WAJ; Klein R. Diabetic retinopathy in Mexican Americans and non-hispanic whites. Diabetes 1988; 37:878-84

Haffner SM; Lehto S; Ronnemaa T; Pyorala K; Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.. NEJM 1998; 339:229-34

Haffner SM. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. NEJM 1998; 339:229-34

Hamman RF; Mayer EJ; Moo-Young GA; Hildebrandt W; Marshall JA; Baxter J. Prevalence and risk factors of diabetic retinopathy in non-Hispanic whites and Hispanics with NIDDM. San Luis Valley Diabetes Study. Diabetes 1989 Oct; 38(10):1231-37

Hanefeld M; Fischer S; Schulze J; Spengler M; Wargenau M; Schollberg K; Fucker K Therapeutic potentials of acarbose as first-line drug in NIDDM insufficiently treated with diet alone. Diabetes Care 1991 Aug; 14(8):732-37

Hansson L; Zanchetti A; Carruthers, SG; Dahlof B; Elmfeldt D; Julius S; Menard J; Rahn KH; Wedel H; Westerling S. for the HOT Study Group. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351:1755-62

Harris MI. Epidemiologic studies on the pathogenesis of non-insulin-dependent diabetes mellitus (NIDDM). Clin Invest Med 1995 Aug; 18(4):231-39

Hasslacher C. Hypertension as a risk factor in non-insulin-dependent diabetes mellitus: how far should blood pressure be reduced? J Diabetes Complications 1997 Mar-Apr; 11(2):90-91

Haupt E; Knick B; Koschinsky T; Liebermeister H; Schneider J; Hirche H. Oral antidiabetic combination therapy with sulphonylureas and metformin. Diabetes Metab 1991 May; 17(1 Pt 2):224-31

Hebel SK. (Ed.). Drug Facts and Comparisons. St. Louis: Facts and Comparisons Inc., 1998

Hemachandra A; Ellis D; Lloyd CE; Orchard TJ. The Influence of Pregnancy on IDDM Complications. Diab Care 1995; 18:950-54

Hermann LS; Schersten B; Bitzen PO; Kjellstrom T; Lindgarde F; Melander A. Therapeutic comparison of metformin and sulfonylurea alone and in various combinations. Diab Care 1994; 17:1100-09

Henricsson M; Nilsson A; Jangon L; Groop L. The Effect of Glycemic Control and the Introduction of Insulin Therapy on Retinopathy in Non-Insulin Dependent Diabetes Mellitus. Diabet Med 1997; 14:123-31

Hoffmann J. Efficacy of 24-week monotherapy with acarbose, metformin, or placebo in dietary-treated NIDDM patients: The Essen-II Study. Am J Med 1997; 103:483-90

Hoffman J; Spengler M; Efficacy of 24-week monotherapy with acarbose, glibenclamide, or placebo in NIDDM patients: the Essen study. Diabetes Care 1994; 17:561-6

Holewski JJ; Stress RM; Graf PM; Grunfeld C. Anesthesiometry: Quantification of cutaneous pressure sensation in diabetic peripheral neuropathy. Journal of Rehabilitation Research and Development 1988; 25:1-10

Holler H; Pastors J. Diabetes Medical Nutrition Therapy. American Dietetic Association, American Diabetes Association Press, c1997

Horton ES; Whitehouse F; Ghazzi MN; Venable TC; Whitcomb RW. Troglitazone in combination with sulfonylurea restores glycemic control in patients with type 2 diabetes. Diab Care 1998; 21:1462-69

Humphrey LL; Ballard DJ; Frohnert PP; Chu CP; O'Fallon WM; Palumbo PJ. Chronic renal failure in non-insulin-dependent diabetes mellitus. A population-based study in Rochester, Minnesota. Ann Intern Med 1989 Nov 15; 111(10):788-96

Hunninghake DB; Miller VT; LaRosa JC; Kinosian B; Jacobson T; Brown V; Howard WJ; Edelman DA; O'Connor RR Long-term treatment of hypercholesterolemia with dietary fiber. Am J Med 1994 Dec; 97(6):504-08

Inzucchi SE; Maggs DG; Spollett GR; Page SL; Rife FS; Walton V; Shulman GI. Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. NEJM 1998; 338:867-72

Iwamoto Y; Kosaka K; Kuzuya T; Akanuma Y; Shigeta Y; Kaneko T. Effect of combination therapy of troglitazone and sulfonylureas in patients with type 2 diabetes who were poorly controlled by sulfonylurea therapy alone. Diabetic Med 1996; 13:365-370

Jaber LA; Halapy H; Fernet M; Tummalapalli S; Diwarkaran H. Evaluation of a pharmaceutical care model on diabetes management. Ann Pharmacother 1996; 30(3):238-43

Jacobson JM; O'Rourke PJ; Wolf AE. Impact of a diabetes teaching program on health care trends in an Air Force Medical Center. Mil Med 1983; 148:46

Javitt C; Conner JK; Sommer A. Cost Effectiveness of Current Approaches to the Control of Retinopathy in Type I Diabetes. Ophthalmology 1989; 96:255-64

Javitt JC; Aiello LP; Chiang Y; Ferris FL 3rd; Canner JK; Greenfield S. Preventive Eye Care in Persons with Diabetes is Cost-Saving to the Federal Government: Implications for health care reform. Diabs Care 1994; 17:909-16

JNC-VI 1997. See Sixth Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure, 1997

Johansen K. Efficacy of metformin in the treatment of NIDDM. Diab Care 1999; 22:33-37

Johnson JL; Wolf SL; Kabadi UM. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. Arch Intern Med 1996; 156:259-64

Kawazu S; Tomono S; Shimizu M; Kato N; Ohno T; Ishii C; Murata K; Watanabe T; Negishi K; Suzuki M; et al. The relationship between early diabetic nephropathy and control of plasma glucose in non-insulin-dependent diabetes mellitus. The effect of glycemic control on the development and progression of diabetic nephropathy in an 8-year follow-up study. J Diabetes Complications 1994 Jan-Mar; 8(1):13-7

Kelley DE; Bidot P; Freedman Z; Haag B; Podlecki D; Rendell M; Schimel D; Weiss S; Taylor T; Krol A; Magner J. Efficacy and safety of acarbose in insulin-treated patients with type 2 diabetes. Diab Care 1998; 21:2056-61

Kim H-K; Kim C-H; Kim S-W; Park J-Y; Hong SK; Yoon YH; Lee KU. Development and Progression of Diabetic Retinopathy in Koreans with NIDDM. Diab Care 1998; 21:134-38

Klein BEK; Moss SE; Klein R. Effect of Pregnancy on Progression of Diabetic Retinopathy. Diab Care 1990; 13:34-40

Klein BEK; Klein R; Wang Q; Moss SE. Older Onset Diabetes and Lens Opacities: The Beaver Dam Eye Study. Invest Ophthalmol Vis Sci 1993; 34:1065

Klein BEK; Klein R; Jensen SC. Open Angle Glaucoma and Older Onset Diabetes: The Beaver Dam Eye Study. Ophthalmology 1994; 101:1173-77

Klein R; Klein BEK; Moss SE; Davis MD; et al: The Wisconsin Study of Diabetic Retinopathy II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984a; 102:520-26

Klein R; Klein BEK; Moss SE; Davis MD; et al: The Wisconsin Study of Diabetic Retinopathy III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984b; 102:527-32

Klein R; Moss SE; Klein BEK; Davis MD; et al: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XI: The incidence of macular edema. Ophthalmology 1989; 96:1501-10

Klein R; Klein BEK; Moss SE; Linton KL. The Beaver Dam Eye Study: Retinopathy in adults with newly discovered and diagnosed diabetes mellitus. Ophthalmology 1992a; 99:58-62

Klein R; Klein BEK; Moss SE. The Epidemiology of Ocular Problems in Diabetes Mellitus. In: Ferman SS (Ed.) Ocular Problems in Diabetes Mellitus. Boston, MA: Blackwell Scientific Publications, c1992b:1-53

Klein R; Moss SE; Klein BEK. Is Gross Proteinuria a Risk Factor for the Incidence of Proliferative Diabetic Retinopathy? Ophthalmology 1993; 100:1140-46

Klein R; Klein BEK; Moss SE; Cruickshanks KJC. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIV: Ten year incidence and progression of diabetic retinopathy. Arch Ophthalmol 1994; 112:1217-28

Klein R: Hyperglycemia and Microvascular and Macrovascular Disease in Diabetes. Kelly West Lecture, 1994. Diab Care 1995a; 18:258-68

Klein R; Klein BEK. Vision Disorders in Diabetes. In: National Diabetes Data Group. Diabetes in America. Second Edition. Bethesda, MD: National Institutes of Health, c1995b; 293-38

Klein W. Sulfonylurea-metformin combination versus sulfonylurea-insulin combination in secondary failures of sulfonylurea monotherapy. Diabetes Metab 1991; 17:235-40

Koda-Kimble MA; Carlisle BA. Diabetes Mellitus. In: Young LY; Koda-Kimble MA (Eds.). Applied Therapeutics: The Clinical Use of Drugs. Sixth Edition. Vancouver: Applied Therapeutics Inc., 1995: 48-1 to 48-62

Kouri TT; Viikari JS; Mattila KS; Irjala KM. Microalbuminuria. Invalidity of simple concentration-based screening tests for early nephropathy due to urinary volumes of diabetic patients. Diab Care 1991 Jul; 14(7):591-93

Kreisberg RA. Cholesterol-lowering and coronary atherosclerosis: good news and bad news. Am J Med 1996; 101:455

Krentz AJ; Ferner RE; Bailey CJ. Comparative tolerability profiles of oral antidiabetic agents. Drug Saf 1994 Oct; 11(4):223-41

Krolewski AS; Warram JH; Freire MBS. Epidemiology of late diabetic complications. A basis for the development and evaluation of preventive programs. Endocrinol Metab Clin North Amer 1996; 25:217

Krumholz HM; Seeman TE; Merrill SS; Mendesde Leon CF; Vaccarino V; Silverman DI; Tsukahara R; Ostfeld AM; Bekman LF. Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years. JAMA 1994; 272:1335-40

Laakso M. Lipids and lipoproteins as risk factors for coronary heart disease in noninsulin-dependent diabetes mellitus. Ann Med 1996; 28:341

Larme AC; Pugh JA. Attitudes of Primary Care Providers Towards Diabetes: Barriers to Guideline Implementation. Diab Care 1998; 21(9):1391-96

Larpent N; Canivet J. Bicentric evaluation of a teaching and treatment programme for type 1 (insulin-dependent) diabetic patients. Diabetologia 1984 Jul; 27(1):62

Lavery LA; Walker SC; Harkless LB; Felder-Johnson K. Infected puncture wounds in diabetic and nondiabetic adults. Diab Care 1995; 18(12):1588-1591

Lee ET; Lee VS; Kingsley RM; Lu M; Russell D; Asal NR; Wilkinson CP; Bradford RH Jr Diabetic retinopathy in Oklahoma Indians with NIDDM. Incidence and risk factors. Diab Care 1992 Nov; 15(11):1620-27

Litzelman DK; Slemanda CW; Langefeld CD. Reduction of lower extremity clinical abnormalities in patients with non-insulin dependent diabetes mellitus. Ann Int Med 1993; 19:36-41

Lucas MJ; Leveno KJ; Williams ML; Raskin P; Whalley PJ. Early pregnancy glycosylated hemoglobin, severity of diabetes, and fetal malformations. Am J Obstet Gynecol 1989 Aug; 161(2):426-31

Lustman PJ; Griffith LS; Freedland KE; Kissel SS; Clouse RD. Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized controlled trial. Ann Intern Med 1998; 129(8):613-21

Marchioli R; Marfisi RM; Carinci F; Tognoni G. Meta-analysis, clinical trials, and transferability of research results into practice. The case of cholesterol-lowering interventions in the secondary prevention of coronary heart disease. Arch Intern Med 1996; 156:1158-72

Marre M; Chatellier G; Leblanc H; Guyenne T-T; Menard J; Passa P. Prevention of Diabetic Nephropathy with Enalapril in Normo-tensive Diabetics with Microalbuminuria. BMJ 1988; 297:1092-95

Marre M; Hallab M; Billiard A; Le Jeune JJ; Bled F; Girault A; Fressinaud P. Small Doses of Ramipril to Reduce Microalbuminuria in Diabetic Patients with Incipient Nephropathy Independently of Blood Pressure Changes. J Cardiovasc Pharmacol 1991; 18(S2):S165-68

Mason RP; Kosoko O; Wilson MR; Cowan CL Jr; Gear JC; Ross-Degnan D. National Survey of the Prevalence and Risk Factors of Glaucoma in St. Lucia, West Indies. Part I: Prevalence findings. Ophthalmology 1989; 96:136-68

Martin AE; Montgomery PA. Acarbose: an a -glucosidase inhibitor. Am J Health-Syst Pharm 1996; 53:2277-90

Mayfield JA; Reiber GE; Nelson RG; Greene T. A Foot Risk Classification System to Predict Diabetic Amputation in Pima Indians. Diab Care 1996; 10:704-9

McGlynn Margaret, Senior Vice President of Merk-Medco Managed Care Inc. Outcomes Study Review. Testimony before the Senate Special Committee on Aging, March 28, 1996

Medical Nutrition Across the Continuum of Care. The American Dietetic Association, Chicago: IL, c1998

Meeting the Standards Manual for the American Diabetes Association. Fifth Edition. The American Diabetes Association, Chicago: IL, c1998

Melchior WR; Jaber LA. Metformin: an antihyperglycemic agent for treatment of type II diabetes. Ann Pharmacother 1996; 30:158-63

Merlo J; Ranstam J; Liedholm H; Hedblad B; Lindberg G; Lindblad U; Isacsson SO; Melander A; Rastam L. Incidence of myocardial infarction in elderly men being treated with antihypertensive drugs: population based cohort study. BMJ 1996 Aug 24; 313(7055):457-61

Merritt JG; Kobernus CA; Hall NJ; Tanenberg RJ. Outcome analysis of a diabetic education clinic. Mil Med 1983; 148:545-47

Miller E; Hare JW; Cloherty JP; Dunn PJ; Gleason RE; Soeldner JS; Kitzmiller JL. Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. NEJM 1981 May 28; 304(22):1331-34

Miller LV; Goldstein J. More Efficient Care of Diabetes in a County Hospital Setting. NEJM 1972; 286:1388-91

Miller ST; Zwagg RV; Joyner MB; Runyan JW Jr. Evaluation of decentralized system for chronic disease care: seven years of observation. Am J Public Health 1980; 70:401-05

Mitchell-Funnel M. A Core Curriculum for Diabetes Education. Third Edition. American Association of Diabetes Educators, c1998

Mogensen CE. Microalbuminuria is a predictor of clinical diabetic nephropathy. Kidney Int 1987; 31:673-89

Monk A; Barry B; McClain K; Weaver T; Cooper N; Franz MJ. Practice guidelines for medical nutrition therapy provided by dietitians for persons with non-insulin dependent diabetes mellitus. J Am Diet Assoc 95(9):999-1006

Morisaki N; Watanabe S; Kobayashi J; Kanzaki T; Takahashi K; Yokote K; Tezuka M; Tashiro J; Inadera H; Saito Y; et al. Diabetic Controls and Progression of Retinopathy in Elderly Patients: Five year follow-up study. J Am Geriatr Soc 1994; 42:142-45

Moses R; Slobodniuk R; Boyages S; Colagiuri S; Kidson W; Carter J; Donnelly T; Moffitt P; Hopkins H. Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes. Diab Care 1999; 22:119-24

Murray JE. Microalbuminuria in Type II Diabetes. Endocrine Practice 1996; 2:211-14

Nakagami T; Kawahara R; Hori S; Omori Y. Glycemic Control and Prevention of Retinopathy in Japanese NIDDM Patients: A 10-year follow–up study. Diab Care 1997; 20:621-622

Nathan DM; Fogel HA; Godine JE; Lou P I. Role of Diabetologist in Evaluating Diabetic Retinopathy. Diab Care 1991; 14:26-33

Nathan D; McKitrick C; Larkin M; Schaffran R; Singer DE. Glycemic control in diabetes mellitus: have changes in therapy made a difference? Am J Med 1996; 100(2):157-63

National Diabetes Advisory Board, National Standards for Diabetes Patient Education Programs. Diab Care 1983; 7:xxxi-xxxv

National High Blood Pressure Education Program Working Group. Report on HTN in Diabetes. Hypertension 1994; 23(2):152

National Standards for Diabetes Self-Management Education Programs and American Diabetes Association Review Criteria. American Diabetes Association. Diab Care 1998; 21:S1

Nauck M; Kramer-Guth A; Bartens W; Marz W; Wieland H; Wanner C. Is the determination of LDL cholesterol according to Friedewald accurate in CAPD and HD patients? Clin Nephrol 1996; 46:319-25

NCEP ATP II 1993. See Summary of the second report of the National Cholesterol Education Program

Nelson RG; Pettitt DJ; Knowler WC; Bennett PH. Prediabetic blood pressure and familial predisposition to renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. J Diabetes Complications 1995 Oct-Dec; 9(4):212-14

Nelson RG; Newman JM; Knowler WC; Sievers ML; Kunzelman CL; Pettitt DJ; Moffett CD; Teutsch SM; Bennett PH. Incidence of end-stage renal disease in type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians. Diabetologia 1988 Oct; 31(10):730-36

Ohkubo Y; Kishikawa H; Araki E; Miyata T; Isami S; Motoyoshi S; Kojima Y; Furuyoshi N; Shichiri M. Intensive Insulin Therapy Prevents the Progression of Diabetic Microvascular Complications in Japanese Patients with Non-Insulin Dependent Diabetes Mellitus: A randomized prospective 6-year study. Diabetes Res Clin Pract 1995; 28:103-17

Oki JC; Flora DL; Isley WL. Frequency and impact of SMBG on glycemic control in patients with NIDDM in an urban teaching hospital. The Diabetes Educator 1997; 23:419-24

O'Donnell MJ; Rowe BR; Lawson N; Horton A; Gyde OH; Barnett AH. Comparison of the effects of an angiotensin converting enzyme inhibitor and a calcium antagonist in hypertensive, macroproteinuric diabetic patients: a randomised double-blind study. J Hum Hypertens 1993 Aug; 7(4):333-39

Orchard TJ; Strandness ED. Assessment of peripheral vascular disease in diabetes. Diabetes Care 1993; 16:1199-1209

Ordonez JD; Hiatt RA. Comparison of type II and type I diabetics treated for end-stage renal disease in a large prepaid health plan population. Nephron 1989; 51:524-29

Padgett D; Mumford E. Meta-analysis of the Effects of Educational and Psychosocial Interventions on Management of Diabetes Mellitis. J Clin Epidemiol 1988; 41:1007-30

Palmberg P; Smith M; Waltman S; Krupin T; Singer P; Burgess D; Wendtlant T; Achtenberg J; Cryer P; Santiago J; White N; Kilo C; Daughaday W. The natural history of retinopathy in insulin-dependent juvenile-onset diabetes. Ophthalmology 1981 Jul; 88(7):613-18

Panzram G. Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1987 Mar; 30(3):123-31

Pascale RW; Wing RR; Butler BA; Mullen M; Bononi P. Effects of behavioral weight loss program stressing calorie restriction versus calorie plus fat restriction in obese individuals with NIDDM or a family history of diabetes. Diab Care 1995; 18(9):1241-48

Pecoraro RE; Reiber GE; Burgess EM. Pathway to diabetic limb amputation. Basis for prevention. Diabetes Care 1990, 1990 13:513-521

Pedersen TR & the Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344:1383

Pedersen TR & the Scandinavian Simvbastatin survival Study Group. Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the scandinavian simvastatin survival study (4S). Circulation 1998; 97:1453-60

Perry JE; Ulbrecht JS; Derr JA; Cavanagh PR. The use of running shoes to reduce plantar pressures in patients who have diabetes. Bone Joint Surg Am 1995 Dec; 77A 77(12):1819-28

Perry TL; Mann JI; Lewis-Barned NJ; Duncan AW; Waldron MA; Thompson C. Lifestyle intervention in people with insulin-dependent diabetes mellitus (IDDM). Eur J Clin Nutr 1997; 51(11):757-63

Peters A. Quality of Care for Patients with Diabetes in HMO Settings in California. (Abstract) May 1995

Pharmacy Benefits Management—Medical Advisory Panel. The Pharmacological Management of Hypertension. VHA PBM-SHG Publication No. 96-0003. Hines, IL: Pharmacy Benefits Management Strategic Health Group, Veterans Health Administration, Department of Veterans Affairs. December 1996

Physicians Desk Reference 1999. Montvale, NJ: Medical Economics Co., 1999

Pyorala K; Steiner G. Will correction of dyslipoproteinaemia reduce coronary heart disease risk in patients with non-insulin-de-pendent diabetes? Need for trial evidence. Ann Med 1996; 28:357

Pyoralka A; Pedersen TR; Kjekshus J; Faergeman O; Olsson AG; Thorgeirsson G; The Scandinavin Simvastatin Survival Study (4S) Group. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. Diab Care 1997; 20(4):614-20

Rabb MF; Gagliano DA; Sweeney HE. Diabetic retinopathy in blacks. Diab Care 1990 Nov; 13(11):1202-06

Ramsey LE; Haq IU; Jackson PR. Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield table. Lancet 1996a; 348:87

Ramsey LE; Haq IU; Jackson PR. The Sheffield table for primary prevention of coronary heart disease: corrected. Lancet 1996b; 348:1251

Ravid M; Savin H; Jutrin I; Bental T; Katz B; Lishner M. Long-term stabilizing effect of angiotensin converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med 1993; 118:577-81

Reiber GE; Boyko EJ; Smith D. Lower extremity foot ulcers and amputations in diabetes. In Diabetes in America 2nd Ed. NIH Publication No. 95-1468. 1995; 409-427

Reichard P; Nilsson B-Y; Rosenqvist U. The effect of long-term intensified treatment on the development of microvascular complications of diabetes mellitus. NEJM 1993; 329:304-09

Report of the Task Force on the Delivery of Diabetes Self-Management Education and Medical Nutrition Therapy. American Diabetes Association Task Force, April 21, 1998

Riddle MC. Tactics for type II diabetes. Endocrin Metab Clin of North Amer 1997; 26:659-77

Rith-Najarian SJ; Stolusky TG; Gohdes DM. Identifying diabetic patients at high risk for lower extremity amputation in a primary health care setting. Diabetes Care 1992; 15:1386-1389

Robinson AC; Burke J; Robinson S; Johnston DG; Elkeles RS. The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control. Diab Care 1998; 21:701-05

Roca-Cusachs A. Lowering blood pressure. How far, how fast? Drugs 1993; 46 Suppl 2:8-14

Rodby RA; Rohde RD; Sharon Z; Pohl MA; Bain RP; Lewis EJ. The urine protein to creatinine ratio as a predictor of 24-hour urine protein excretion in type 1 diabetic patients with nephropathy. The Collaborative Study Group. Am J Kidney Dis 1995 Dec; 26(6):904-9

Romero R; Salinas I; Lucas A; Abad E; Reverter JL; Johnston S; Sanmarti A Renal function changes in microalbuminuric normotensive type II diabetic patients treated with angiotensin-converting enzyme inhibitors. Diabetes Care 1993 Apr; 16(4):597-600

Rose BD. Up to Date in Medicine. Wellesley, MA: c1999

Rosenstock J; Brown A; Fischer J; Jain A; Littlejohn T; Nadeau D; Sussman A; Taylor T; Krol A; Magner J. Efficacy and safety of acarbose in metformin-treated patients with type 2 diabetes. Diab Care 1998; 21:2050-55

Rubin RJ; Dietrich KA; Hawk AD. Clinical and Economic Impact of Implementing a Comprehensive Diabetes Management Program in Managed Care. J Clin Endocrinol Metabol 1998; 83(8):2635-42

Sacks FM; Pfeffer MA; Moye LA; Rouleau JL; Rutheford JD; Cole TG; Brown L; Warnica JW; Arnold JM; Wunce S; Davis BR; Braunwald E. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial Investigators. NEJM 1996; 335:1001

Savage S; Estacio R; Jeffers B; Schrier R. Urinary Albumin Excretion as a Predictor of Diabetic Retinopathy, Neuropathy, and Cardiovascular Disease in NIDDM. Diab Care 1996; 19:1243-48

Savage S; Estacio RO; Jeffers B; Schrier RW. Increased Complications in Non-Insulin Dependent Diabetic Patients Treated with Insulin versus Oral Hypoglycemic Agents: A population study. Proc Assoc Am Physicians 1997; 109:181-89

Scheen AJ; Lefebvre PJ. Oral antidiabetic agents: A guide to selection. Drugs 1998; 55:225-36

Scheffler RM; Feuchtbaum LB; Phibbs CS. Prevention: The Cost Effectiveness of the California Diabetes and Pregnancy Program. Am J Pub Health 1992 82(2):168-75

Schlunddt DG; Rea MR; Kline SS; Pichert JW. Situational obstacles to dietary adherence for adults with diabetes. J Am Diet Assoc 94(8):874-6, 879

Schmid H; Schaan B; Cecconello F; Maestri T. Proliferative Diabetic Retinopathy is Related to Cardiovascular Autonomic Neuropathy in Non-Insulin Dependent Diabetes Mellitus. Diabetes Res Clin Pract 1995; 29:163-68

Schrier RW (Ed.). Renal and Electrolyte Disorders. Boston, MA: Little, Brown and Company, c1976

Schwab SJ; Christensen RL; Dougherty K; Klahr S. Quantitation of proteinuria by the use of protein-to-creatinine ratios in single urine samples. Arch Intern Med 1987 May; 147(5):943-44

Schwartz S; Raskin P; Fonseca V; Graveline JF. Effect of troglitazone in insulin-treated patients with type II diabetes mellitus. NEJM 1998; 338:861-66

Self-Management Education Programs and American Diabetes Association Review Criteria. Diabs Care 1999; 22(S1):111-14

Shepherd J; Cobbe SM; Ford I; Isles CG; Lorime AR; MacFarlane PW; McKillop JH; Packard CJ. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. NEJM 1995; 333:1301-07

Sikka R; Waters J; Moore W; Sutton DR; Herman WH; Aubert RA. Renal assessment of practices and the effect of nurse case management of health maintenance organization patients with diabetes. Diab Care 1999; 22:1-6

Sims DS Jr; Cavanaugh PR; Ulbrecht JS. Risk factors in the diabetic foot. The Journal of the American Physical Therapy Association 1988; 68:1887-1902

Singer DE; Nathan DM; Fogel HA; Schachat AP. Screening for diabetic retinopathy. Ann Intern Med 1992; 116:660-71

Sommer A; Tielsch JM; Katz J; Quigley HA. Relationship between intraocular pressure and primary open angle glaucoma among white and black americans: The Baltimore eye survey. Arch Ophthalmol 1991; 109:1090-95

Soneru IL; Agrawal L; Murphy JC. Comparison of morning or bedtime insulin with and without glyburide in secondary sulfonylurea failure. Diab Care 1993; 16:896-901

Sperduto RD; Hiller R; Chew E; Seigel D; Blair N; Burton TC; Farber MD; Gragoudas ES; Haller J; Seddon JM; Yannuzzi LA. Risk Factors for Hemiretinal Vein Occlusion: Comparison with risk factors for central and branch retinal vein occlusion. The Eye Disease Case Control Study. Ophthalmology 1998; 105:765-71

State of Maine. DHHS Reimbursement Pilot Study for the Ambulatory Diabetic Education and Follow-up (ADEF) Program: Final Report. Augusta, ME: 1983

Sparano N; Seaton TL. Troglitazone in type II diabetes mellitus. Pharmacotherapy 1998; 18(3):539-48

Steil CF. Diabetes Mellitus. In: DiPiro JT; Talbert RL; Yee GC; Matzke GR; Wells BG; Posey LM (Eds.). Pharmacotherapy: A pathophysiologic approach. Third Edition. New York, NY: Elsevier, Appleton & Lange. 1997:1489-1518

State of Maine. DHHS Reimbursement pilot study for the ambulatory diabetic education and follow-up (ADEF) program: Final Report Augusta, 1983

Stone NJ. Management of Lipids in Clinical Practice. 1997 Professional Communications, Inc. ISBN 1-884735-22-3

Stumvoll M; Nurjahn N; Perrielo G; et al. Metabolic effects of metformin in non-insulin dependent diabetes mellitus. NEJM 1995; 333:550-54

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA 1993; 269(23):3015-23

Sweany AE; Shapiro DR; Tate AC; Goldbeg RB; Stein EA. Effects of simvastatin versus gemfibrozil on lipids and glucose control in patients with non-insulin dependent diabetes mellitus control in patients with non-insulin dependent diabetes mellitus. Clin Ther 1995; 17:186-203

The Sixth Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. Arch Int Med 1997; 157:2413-46

Tatti P; Pahor M; Byington RP; DiMauro P; Guarisco R; Strollo G; Stroll F. Outcome Results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in Persons with Hypertension and NIDDM. Diab Care 1998; 21:597-603

Tielsch JM; Sommer A; Katz J; Royall RM; Quigley HA; Javitt J. Racial Variations in the Prevalence of Primary Open-Angle Glaucoma: The Baltimore Eye Survey. JAMA 1991; 266:369-74

Tielsch JM; Katz J; Sommer A; Quigley HA; Javitt JC. Family History and Risk of Primary Open Angle Glaucoma: The Baltimore Eye Survey. Arch Ophthalmol 1994; 112:69-73

Tielsch JM; Katz J; Quigley HA; Javitt JC; Sommer A. Diabetes, Intraocular Pressure, and Primary Open-Angle Glaucoma in the Baltimore Eye Survey. Ophthalmology 1995; 102:48-53

Toto RD; Kirk KA; Coresh J; Jones C; Appel L; Wright J; Campese V; Olutade B; Agodoa L. Evaluation of serum creatinine for estimating glomerular filtrationm rate in African Americans with hypertensive nephrosclerosis: results from the African American Study of Kidney Disease and Hypertension (AASK) Pilor Study. J Am Soc Nephrol 1997; 8(2):279-87

Travis T. Patient perceptions of factors that affect adherence to dietary regimens for diabetes mellitus. Diabetes Educator 1997; 23(2):152-56

Trischitta V; Italia S; Mazzarino S; Buscema M; Rabuazzo AM; Sangiorgio L; Squatrito S; Vigneri R. Comparison of therapies in treatment of secondary failure to glyburide. Diab Care 1992; 15:539-41

Uccioli L; et al. Manufactured shoes in the prevention of diabetic foot ulcers. Diabetes Care 1995. 18(10) 1376-1378

United Kingdom Prospective Diabetes Study Group (UKPDS): Intensive Blood-Glucose Control with Sulphonylureas or Insulin Compared with Conventional Treatment and Risk of Complications in Patients with Type-2 Diabetes. Lancet 1998; 352:837-53

United Kingdom Prospective Diabetes Study. UKPDS 24. A 6-Year, Randomized, Controlled Trial Comparing Sulfonylurea, Insulin, and Metformin Therapy in Patients with Newly Diagnosed Type 2 Diabetes That Could Not Be Controlled with Diet Therapy. BMJ 1988; 128:165-75

United Kingdom Prospective Diabetes Study Group. UKPDS 33. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998; 353:837-53

United Kingdom Prospective Diabetes Study Group. UKPDS 34. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes. Lancet 1998; 352:854-65

United Kingdom Prospective Diabetes Study. UKPDS 38. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. BMJ 1998; 317:703-13

United Kingdom Prospective Diabetes Study. UKPDS 39. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes. BMJ 1998; 317:713-20

U.S. Department of Health and Human Services. National Health Promotion and Disease Prevention Objectives. Health People 2000. Washington, DC: 1991. DHHS (PHS) publication 91-50212

U.S. Preventive Services Task Force. Guide to Clinical Preventive Services. Second edition. Baltimore, MD: Williams & Wilkins, 1996

Veterans Healh Administration. Diabetes Mellitus Working Group. Clinical Guideline for the Management of Diabetes Mellitus. Version 1.0. March 31, 1997

Veterans Health Administration. Diabetes Mellitus Working Group. A PBM-MAP guideline for the Pharmacological Management of Hyperlipidemia. n/d. www.dppm.med.va.gov

Walker JD; Bending JJ; Dodds RA; Mattock MB; Murrells TJ; Keen H; Viberti GC. Restriction of Dietary Protein and Progression of Renal Failture in Diabetic Nephropathy. Lancet 1989; 2:1411-15

Wang F. Focus on repaglinide: an oral hypoglycemic agent with a more rapid onset and shorter duration of action than the sulfonylureas. Formulary 1998; 33:409-23

Weir GC; Nathan DM; Singer DE. Technical Review. Standards of Care for Diabetes. Diabetes Care 1994; 17:114-22

Whiting MJ; Shephard MDS; Tallis GA. Measurement of plasma LDL cholesterol in patients with diabetes. Diab Care 1997; 20:12

Wieland LD; Vigil JM; Hofffman RM; Janis LW. Relationship between home glucose testing and hemoglobin A1c in type 2 diabetes patients. Am J Health-syst Pharm 1997; 54:1062-65

Wolffenbuttel BHR; Landgraf R. A 1-year multicenter randomized double-blind comparison of repaglinide and glyburide for the treatment of type 2 diabetes. Diab Care 1999; 22:463-67

Wolffenbuttel BH; Sels JP; Rondas-Colbers G; Menheere PP; Nieuwenhuijzen Kruseman AC. Comparison of different insulin regimens in elderly patients with NIDDM. Diab Care 1996; 19:1326-32

Yki-Jarvinen H; Kauppilla M; Kujansuu E; Lahti J; Marjanen T; Niskanen L; Rajala S; Ryysy L; Salo S, Seppala P; et al. Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus. NEJM 1992; 327:1426-33

Yki-Jarvinen H; Ryysy L; Nikkila K; Tulokas T; Vanamo R; Heikkila M. Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. Ann Intern Med 1999; 130:389-96

Young MJ; Cavanagh PR; Thomas MM; Johnson HM; Boulton AJM. The effect of callus removal on Diabetics. Diabetic Med 1992; 9:55-57

Zeller K; Whittaker E; Sullivan L; Raskin P; Jacobson HR. Effect of Restricting Dietary Protein on the Progression of Renal Failure in Patients with Insulin-Dependent Diabetes Mellitus. NEJM 1991; 324:78-84

Zimmerman BR; Espenshade J; Fujimoto WF. The pharmacologic treatment of hyperglycemia in NIDDM. Diab Care 1995; 18:1510-18